Persistence of cognitive impairment in geriatric patients following antidepressant treatment: a randomized, double-blind clinical trial with nortriptyline and paroxetine

Clinical Trial

Robert D Nebes et al. J Psychiatr Res. 2003 Mar-Apr.

Abstract

Cognitive dysfunction is common in older persons suffering from a major depression. However, the degree to which this dysfunction is reversible with successful treatment of the depression remains uncertain. The present study examined the effects that treatment (randomized double-blind design) with either an SSRI (paroxetine) or a tricyclic antidepressant (nortriptyline) had on cognition in older depressed patients. The patients' performance was compared to that of a group of normal controls of similar age and education. Patients and controls were administered measures of working memory, information-processing speed, episodic memory and attention five times over the course of a 12 week trial. At baseline, the patients performed more poorly than the elderly controls on all cognitive measures. While the patients' performance did improve over the course of their treatment, the magnitude of this improvement did not exceed that produced in the elderly controls by practice alone. The same pattern of results was evident in both intent-to-treat and responder analyses. Thus, there was no evidence that the depressed patients' cognitive performance normalized after response to antidepressant therapy. Neither the patients' age at onset nor their baseline level of cognitive functioning influenced the amount by which their performance improved over the 12 week trial. There was no difference between paroxetine and nortriptyline in the amount of cognitive change associated with treatment. The present results suggest that cognitive dysfunction persists in older depressed patients even after their mood disorder has responded to antidepressant medications.

PubMed Disclaimer

Cited by

The double burden of age and major depressive disorder on the cognitive control network.
Rao JA, Kassel MT, Weldon AL, Avery ET, Briceno EM, Mann M, Cornett B, Kales HC, Zubieta JK, Welsh RC, Langenecker SA, Weisenbach SL. Rao JA, et al. Psychol Aging. 2015 Jun;30(2):475-85. doi: 10.1037/pag0000027. Psychol Aging. 2015. PMID: 26030776 Free PMC article.
Altered functional connectivity networks of hippocampal subregions in remitted late-onset depression: a longitudinal resting-state study.
Wang Z, Yuan Y, Bai F, Shu H, You J, Li L, Zhang Z. Wang Z, et al. Neurosci Bull. 2015 Feb;31(1):13-21. doi: 10.1007/s12264-014-1489-1. Epub 2015 Jan 6. Neurosci Bull. 2015. PMID: 25564192 Free PMC article.
Association between Changes in Depressive State and Cognitive Function.
Kim JH, Kim Y, Kwon J, Park EC. Kim JH, et al. Int J Environ Res Public Health. 2019 Dec 6;16(24):4944. doi: 10.3390/ijerph16244944. Int J Environ Res Public Health. 2019. PMID: 31817584 Free PMC article.
Cognitive decline in patients with dementia as a function of depression.
Rapp MA, Schnaider-Beeri M, Wysocki M, Guerrero-Berroa E, Grossman HT, Heinz A, Haroutunian V. Rapp MA, et al. Am J Geriatr Psychiatry. 2011 Apr;19(4):357-63. doi: 10.1097/JGP.0b013e3181e898d0. Am J Geriatr Psychiatry. 2011. PMID: 20808140 Free PMC article.
Subjective perception of cognition is related to mood and not performance.
Marino SE, Meador KJ, Loring DW, Okun MS, Fernandez HH, Fessler AJ, Kustra RP, Miller JM, Ray PG, Roy A, Schoenberg MR, Vahle VJ, Werz MA. Marino SE, et al. Epilepsy Behav. 2009 Mar;14(3):459-64. doi: 10.1016/j.yebeh.2008.12.007. Epub 2009 Jan 6. Epilepsy Behav. 2009. PMID: 19130899 Free PMC article. Clinical Trial.

Persistence of cognitive impairment in geriatric patients following antidepressant treatment: a randomized, double-blind clinical trial with nortriptyline and paroxetine - PubMed (original) (raw)